Your browser doesn't support javascript.
loading
Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care.
Mullens, Wilfried; Auricchio, Angelo; Martens, Pieter; Witte, Klaus; Cowie, Martin R; Delgado, Victoria; Dickstein, Kenneth; Linde, Cecilia; Vernooy, Kevin; Leyva, Francisco; Bauersachs, Johann; Israel, Carsten W; Lund, Lars; Donal, Erwan; Boriani, Giuseppe; Jaarsma, Tiny; Berruezo, Antonio; Traykov, Vassil; Yousef, Zaheer; Kalarus, Zbigniew; Cosedis Nielsen, Jens; Steffel, Jan; Vardas, Panos; Coats, Andrew; Seferovic, Petar; Edvardsen, Thor; Heidbuchel, Hein; Ruschitzka, Frank; Leclercq, Christophe.
Afiliación
  • Mullens W; Ziekenhuis Oost Limburg, Genk, - University Hasselt, Hasselt, both in Belgium.
  • Auricchio A; Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland.
  • Martens P; Ziekenhuis Oost Limburg, Genk, - University Hasselt, Hasselt, both in Belgium.
  • Witte K; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Cowie MR; Imperial College London (Royal Brompton Hospital), London, United Kingdom.
  • Delgado V; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Dickstein K; University of Bergen, Stavanger University Hospital, Norway.
  • Linde C; Heart and Vascular Theme, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
  • Vernooy K; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, and Department of Cardiology, Radboud University Medical Center (Radboudumc), Nijmegen, both in the Netherlands.
  • Leyva F; Aston Medical School, Birmingham, United Kingdom.
  • Bauersachs J; Hannover Medical School, Department of Cardiology and Angiology, Hannover.
  • Israel CW; Department of Medicine - Cardiology, Diabetology and Nephrology, Bethel-Clinic, Bielefeld, Germany.
  • Lund L; Department of Medicine Karolinska Institutet, and Department of Cardiology, Karolinska, University Hospital.
  • Donal E; Cardiologie - CHU Rennes - LTSI Inserm UMR 1099 - Université Rennes-1, Rennes.
  • Boriani G; Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Jaarsma T; Julius Center, University Medical Center Utrecht, the Netherlands and Department of Health, Medicine and Caring Science, Linköping University; Sweden.
  • Berruezo A; Heart Institute, Teknon Medical Center. Barcelona. Spain.
  • Traykov V; Department of Cardiology, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria.
  • Yousef Z; Department of Cardiology, University Hospital of Wales & Cardiff University.
  • Kalarus Z; Medical University of Silesia, Katowice, Poland Department of Cardiology.
  • Cosedis Nielsen J; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Steffel J; UniversitätsSpital Zürich, Zürich, Switzerland.
  • Vardas P; Heart Sector, Hygeia Hospitals Group, Athens, Greece.
  • Coats A; IRCCS San Raffaele Pisana, Rome, Italy.
  • Seferovic P; Faculty of Medicine, Serbian Academy of Science and Arts, Belgrade University Belgrade, Serbia.
  • Edvardsen T; Dept of Cardiology, Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, Norway.
  • Heidbuchel H; Antwerp University and Antwerp University Hospital, Antwerp, Belgium.
  • Ruschitzka F; Heart and Vascular Theme, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
  • Leclercq C; Department of Cardiology, University Hospital, University Heart Center, Zurich, Switzerland.
Europace ; 2021 Feb 05.
Article en En | MEDLINE | ID: mdl-33544835
ABSTRACT
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heartfailure hospitalization rates and reduces all-cause mortality. Nevertheless, up to two-thirds ofeligible patients are not referred for CRT. Furthermore, post implantation follow-up is oftenfragmented and suboptimal, hampering the potential maximal treatment effect. This jointposition statement from three ESC Associations, HFA, EHRA and EACVI focuses onoptimized implementation of CRT. We offer theoretical and practical strategies to achievemore comprehensive CRT referral and post-procedural care by focusing on four actionabledomains; (I) overcoming CRT under-utilization, (II) better understanding of pre-implantcharacteristics, (III) abandoning the term 'non-response' and replacing this by the concept ofdisease modification, and (IV) implementing a dedicated post-implant CRT care pathway.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Europace Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Europace Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2021 Tipo del documento: Article